Butabarbital decreases consequences of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Coadministration of CYP3A4 inducers could lessen sufentanil stages and efficacy, potentially precipitating withdrawal syndrome in people that have made physical dependence to sufentanil. Discontinuation of concomitantly employed CYP3A4 inducers... https://friedrichi228exs2.azzablog.com/profile